Market capitalization | CHF263.26m |
Enterprise Value | CHF519.56m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.40 |
P/S ratio (TTM) P/S ratio | 0.20 |
P/B ratio (TTM) P/B ratio | 1.09 |
Revenue (TTM) Revenue | CHF1.30b |
EBIT (operating result TTM) EBIT | CHF-117.70m |
As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.
11 Analysts have issued a DocMorris forecast:
11 Analysts have issued a DocMorris forecast:
Mar '25 |
+/-
%
|
||
Revenue | 1,298 1,298 |
-
|
|
Gross Profit | 278 278 |
-
|
|
EBITDA | -60 -60 |
-
|
EBIT (Operating Income) EBIT | -118 -118 |
-
|
Net Profit | -122 -122 |
-
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
DocMorris Ltd. engages in the operation of an e-commerce pharmacy and the wholesale of medical and pharmaceutical products. It operates through the following geograpical segments: Switzerland, Germany, and Europe. The company was founded by Walter Oberhänsli on April 6, 1993 and is headquartered in Frauenfeld, Switzerland.
Head office | Switzerland |
CEO | Walter Hess |
Employees | 1,454 |
Founded | 1993 |
Website | corporate.docmorris.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.